Monster Beverage Corp·4

May 15, 6:00 PM ET

Tirre Emelie 4

4 · Monster Beverage Corp · Filed May 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Monster (MNST) Chief Strategy Officer Emelie Tirre Exercises Options, Sells Shares

What Happened

  • Emelie Tirre, Chief Strategy Officer of Monster Beverage Corp (MNST), exercised multiple stock option tranches and then sold shares in the open market. She exercised a total of 90,948 option shares on May 13–14, 2026, paying approximately $4,102,815 in aggregate exercise price. Immediately around those exercises she sold 88,700 shares on May 13 and 10,000 shares on May 14 for total gross proceeds of $8,482,052.

Key Details

  • Exercise (acquired): 17,752 @ $44.47 ($789,431); 32,200 @ $36.62 ($1,179,164); 28,998 @ $50.82 ($1,473,678); 4,500 @ $60.30 ($271,350); 5,250 @ $55.09 ($289,223); 2,248 @ $44.47 ($99,969). Total acquired via exercise = 90,948 shares; total exercise cost ≈ $4,102,815.
  • Sales (disposed): 88,700 shares on 2026-05-13 for $7,624,652 (weighted avg $85.96; trades ranged $85.72–$86.27 per footnote F1); 10,000 shares on 2026-05-14 for $857,400 (weighted avg $85.74; trades ranged $85.73–$85.80 per F2). Total sale proceeds ≈ $8,482,052.
  • Derivative disposals at $0 reported reflect the options being converted/terminated upon exercise (standard reporting of option-to-share conversion).
  • Vesting: the filing notes the exercised options were currently vested for the reported share amounts (see footnotes F3–F9 for specific vesting detail and remaining vesting schedules).
  • Shares owned after transaction: not specified in the filing.
  • Filing timeliness: Reported on Form 4 filed May 15, 2026 for transactions on May 13–14, 2026 (filed within the standard Form 4 deadline).

Context

  • This pattern — exercising vested options and immediately selling some or all resulting shares — is common (a cashless or partial cashless approach) to cover exercise costs, taxes, or diversify. The filing is factual and does not state a trading plan; it shows both option exercises (code M) and open‑market sales (code S).

Insider Transaction Report

Form 4
Period: 2026-05-13
Tirre Emelie
Chief Strategy Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-13$44.47/sh+17,752$789,43199,515 total
  • Exercise/Conversion

    Common Stock

    2026-05-13$36.62/sh+32,200$1,179,164131,715 total
  • Exercise/Conversion

    Common Stock

    2026-05-13$50.82/sh+28,998$1,473,678160,713 total
  • Exercise/Conversion

    Common Stock

    2026-05-13$60.30/sh+4,500$271,350165,213 total
  • Exercise/Conversion

    Common Stock

    2026-05-13$55.09/sh+5,250$289,223170,463 total
  • Sale

    Common Stock

    [F1]
    2026-05-13$85.96/sh88,700$7,624,65281,763 total
  • Sale

    Common Stock

    [F2]
    2026-05-14$85.74/sh10,000$857,40071,763 total
  • Exercise/Conversion

    Common Stock

    2026-05-14$44.47/sh+2,248$99,96974,011 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F3][F4]
    2026-05-1320,0000 total
    Exercise: $44.47Exp: 2031-03-12Common Stock (20,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F5]
    2026-05-1332,20013,800 total
    Exercise: $36.62Exp: 2032-03-14Common Stock (32,200 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F6]
    2026-05-138,99811,000 total
    Exercise: $50.82Exp: 2033-03-14Common Stock (8,998 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F4]
    2026-05-1320,0000 total
    Exercise: $50.82Exp: 2033-03-14Common Stock (20,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F7]
    2026-05-134,50013,500 total
    Exercise: $60.30Exp: 2034-03-14Common Stock (4,500 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F8]
    2026-05-135,25015,750 total
    Exercise: $55.09Exp: 2035-03-14Common Stock (5,250 underlying)
Holdings
  • Employee Stock Option (right to buy)

    [F9][F10]
    Exercise: $77.11Exp: 2036-03-13Common Stock
    11,700
  • Restricted Stock Units

    [F11][F12][F13][F10]
    Common Stock
    4,080
  • Restricted Stock Units

    [F11][F14][F13][F10]
    Common Stock
    3,740
  • Restricted Stock Units

    [F11][F15][F13][F10]
    Common Stock
    4,500
  • Restricted Stock Units

    [F11][F16][F13][F10]
    Common Stock
    5,250
  • Restricted Stock Units

    [F11][F17][F13][F10]
    Common Stock
    3,900
Footnotes (17)
  • [F1]This transaction was executed in multiple trades at prices ranging from $85.72 to $86.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F10]No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.
  • [F11]The restricted stock units were granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date.
  • [F12]The restricted stock units vest on March 14, 2027.
  • [F13]Not applicable.
  • [F14]The restricted stock units vest in two installments as follows: 1,700 units on March 14, 2027 and 2,040 units on March 14, 2028.
  • [F15]The restricted stock units vest in three installments as follows: 1,200 units on March 14, 2027; 1,500 units on March 14, 2028 and 1,800 units on March 14, 2029.
  • [F16]The restricted stock units vest in three equal installments on March 14, 2027, March 14, 2028 and March 14, 2029.
  • [F17]The restricted stock units vest in three equal installments on March 13, 2027, March 13, 2028 and March 13, 2029.
  • [F2]This transaction was executed in multiple trades at prices ranging from $85.73 to $85.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]17,752 shares were exercised on May 13, 2026 and 2,248 shares were exercised on May 14, 2026.
  • [F4]The options are currently vested.
  • [F5]The options are currently vested with respect to 32,200 shares. The remaining options vest on March 14, 2027.
  • [F6]The options are currently vested with respect to 8,998 shares. The remaining options vest in two installments as follows: 5,000 shares on March 14, 2027 and 6,000 shares on March 14, 2028.
  • [F7]The options are currently vested with respect to 4,500 shares. The remaining options vest in three installments as follows: 3,600 shares on March 14, 2027; 4,500 shares on March 14, 2028 and 5,400 shares on March 14, 2029.
  • [F8]The options are currently vested with respect to 5,250 shares. The remaining options vest in three equal installments on March 14, 2027, March 14, 2028 and March 14, 2029.
  • [F9]The options vest in three equal installments on March 13, 2027, March 13, 2028 and March 13, 2029.
Signature
/s/ Paul J. Dechary, Attorney-in-Fact|2026-05-15

Documents

1 file
  • 4
    form4-05152026_060517.xmlPrimary